Plasma proteomics reveals tissue-specific cell death and mediators of cell-cell interactions in severe COVID-19 patients
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
COVID-19 has caused over 1 million deaths globally, yet the cellular mechanisms underlying severe disease remain poorly understood. By analyzing several thousand plasma proteins in 306 COVID-19 patients and 78 symptomatic controls over serial timepoints using two complementary approaches, we uncover COVID-19 host immune and non-immune proteins not previously linked to this disease. Integration of plasma proteomics with nine published scRNAseq datasets shows that SARS-CoV-2 infection upregulates monocyte/macrophage, plasmablast, and T cell effector proteins. By comparing patients who died to severely ill patients who survived, we identify dynamic immunomodulatory and tissue-associated proteins associated with survival, providing insights into which host responses are beneficial and which are detrimental to survival. We identify intracellular death signatures from specific tissues and cell types, and by associating these with angiotensin converting enzyme 2 (ACE2) expression, we map tissue damage associated with severe disease and propose which damage results from direct viral infection rather than from indirect effects of illness. We find that disease severity in lung tissue is driven by myeloid cell phenotypes and cell-cell interactions with lung epithelial cells and T cells. Based on these results, we propose a model of immune and epithelial cell interactions that drive cell-type specific and tissue-specific damage in severe COVID-19.
Article activity feed
-
SciScore for 10.1101/2020.11.02.365536: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources All plots were generated using the ggplot2 package in R with the exception that the correlation plots were generated using the corrplot() function in R. ggplot2suggested: (ggplot2, RRID:SCR_014601)Organ signatures were split based on localization (intracellular versus membrane/secreted) using UniProt and literature annotations. UniProtsuggested: (UniProtKB, RRID:SCR_004426)Python 3.8 was used to run the python package Cellphonedb v2.1.4 with the following parameters: database v2.0.0, statistical method analysis, 1000 iterations, 6000 cell subsampling. Pythonsuggested: (IPython, RRID:SCR_00165…SciScore for 10.1101/2020.11.02.365536: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources All plots were generated using the ggplot2 package in R with the exception that the correlation plots were generated using the corrplot() function in R. ggplot2suggested: (ggplot2, RRID:SCR_014601)Organ signatures were split based on localization (intracellular versus membrane/secreted) using UniProt and literature annotations. UniProtsuggested: (UniProtKB, RRID:SCR_004426)Python 3.8 was used to run the python package Cellphonedb v2.1.4 with the following parameters: database v2.0.0, statistical method analysis, 1000 iterations, 6000 cell subsampling. Pythonsuggested: (IPython, RRID:SCR_001658)Cellphonedbsuggested: (CellPhoneDB, RRID:SCR_017054)Results from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
